+++ Stock Ticker +++ – Disappointing balance sheets and the strength of the dollar put the US stock market at | new

Business



[ad_1]

22:30

The Dow Jones Standards Index closed down 0.5% to 25,064 points. The S & P 500 index lost 0.4% to settle at 2,804 meters. The Nasdaq technology exchange index fell 0.4 percent to 7825 points.

After the price gains of recent days taking profit quite appropriate, said a dealer. In addition, some companies could not meet the high expectations of investors.

Stock markets briefly reduced their losses after Trump criticized US Federal Reserve interest rate hikes. "I'm not happy," he told CNBC television. After each increase, the monetary authorities wanted to raise interest rates. "I'm not happy about that," said Trump. "But at the same time, I let them do what they think is the best."

Some companies throw long shadows on the market. So, Ebay has been crushed by more than ten percent. The online auction house has cut its revenue goals due to weak business at its online StubHub ticket retailer. Alcoa also fell by more than 13%, as the aluminum company in the second quarter felt the effects of US customs policy and thus lowered its earnings guidance.

However, there were also some positives: IBM, the world's largest IT service provider. Investors with increased sales and profits. Newspapers grew 3.3%, making it one of the Dow's biggest winners. Walt Disney gained 1.3%. The US cable giant, Comcast, is running for 21st Century Fox's film and television industry, of which Disney is finally free for Fox at Fox

+++

17:30 [19659002] The Swiss Stock Exchange lost ground Thursday late in the session following a weaker opening on Wall Street. The SMI was lower at 8934 points. The day before, the leading index had risen 1.3 percent to its highest level since the end of May. Even better than expected in the United States, economic data may be only briefly apparent

. A flood of semi-annual figures from home and abroad has caused mixed feelings. Market participants continued to worry about the consequences of the US trade dispute. "After the stock market rally of the day before, the profit taking was already great," says a distributor

. The focus has been on ABB shares, up 2.8% after the half-year report. Despite the steady decline in sales, the electrical engineering group gained more in the second quarter of 2018. Earnings climbed 30% to $ 681 million, outperforming analysts' estimates.

Givaudan shocked shareholders with a drop in shares: stocks slid 3.7%

For heavyweights, disappointing results 1.2%

Financials held banks, while l 39; insurance fell slightly.

Starting from the second row, many companies made a lot of noise: in Dormakaba, the share lost nearly a fifth of the value and recorded one of the darkest days in the world. History of the Schliesstechnikfirma.

Rieter shares collapsed 14.7 percent. The textile machinery manufacturer expects a decline in profits in the first half with less profit for the whole year.

The title of Temenos fell by 4.8%. The banking software publisher increased its profit by a quarter to the second quarter and confirmed the forecast for 2018.

The Leonteq stock plunged 11.1%. This is not the result on the market that is responsible for it, but an unexpected capital increase.

Meyer Burger dropped 14.8%. The solar supplier hit the black again. However, the company has disappointed with the order intake, said a trader

Read the detailed SMI final report here.

+++

17:06

Ophthalmic drug test results Abicipar Shares of the Swiss biotech company Molecular Partners on Thursday led to a roller coaster ride. Shares of Schlieren, near Zurich, climbed 14.5 percent to 25.65 francs at the moment. Phase III clinical trials have questioned the efficacy of the drug developed with US partner Allergan. Abicipar will be used against age-related macular degeneration (AMD). The most advanced drug of the young company must exist after a license against billions of drugs already well established as Lucentis of Roche and Novartis.

In the aftermath of the trade, however, skeptics gained the upper hand and the title lost 13% to 19.50 Swiss francs. Although Abicipar has the advantage for patients that fewer eye injections are needed than competing products. At the same time, the drug has the disadvantage of leading more often to eye inflammation than other agents. Molecular Partners was confident that it would be able to control the contaminants in the manufacturing process and thus decrease the rate of inflammation.

+++

16:06

Philip Morris falls to 6, 9 percent to $ 76.52. The supplier of "Marlboro" and the e-cigarette "iQOS" had reduced its earnings forecast. In the current year, shipments of cigarettes and e-cigarettes are falling, the company said. Rival Altria's shares fell by 3.9%

+++

15:45

Disappointing interim reports of some large companies also spoiled investors in New York on Thursday . The Dow Jones and the S & P 500 slipped 0.3% in the early trading minutes. The Nasdaq composite also gave way. After the price gains of recent days, taking profits quite appropriately, said a dealer. In addition, some companies could not meet the high expectations of investors.

So, Ebay has dropped more than seven percent. The online auction house had reduced its sales targets due to the sluggishness of transactions at its online StubHub ticket retailer.

Alcoa also saw a long face, losing more than five percent. The aluminum company was hit by the consequences of the US customs policy in the second quarter and thus lowered its profit forecasts.

IBM, the world's largest IT service provider, has higher sales and profits. Securities listed on the Dow rose more than three percent, leading the list of winners.

+++ [19659002] 15:36

With a 21% increase in profits, American Express failed to convince investors. Dow Jones listed stocks fell three percent in New York to $ 99.90. In competition with major banks such as JP Morgan and Citigroup, the credit card issuer had increased its spending on loyalty programs in the second quarter. They rose eleven percent to $ 2.43 billion.

+++

15:10

The Chinese yuan dropped to a one-year low after the central bank has little signs of intervention have shown to slow down the decline of the national currency. The yuan fell 0.85% to 6.8032 dollars per dollar, its lowest level since July 2017. The People's Bank of China (PBOC) has fixed its fixing above 6 Thursday for the first time since the beginning of the downtrend, 7 weakened. Signs of further monetary easing also accentuate the pressure and, according to a China Business News report, policymakers have made efforts to promote bank credit and investment in corporate bonds to low rate.

Percent, the worst performance among the 31 major currencies after the economy in the world's second largest economy faltered and a trade dispute with the United States rose. China will tolerate greater yuan volatility and a moderate weakening of the currency as long as financial stability is not threatened, says Pimco.

+++

14:04

Declining demand following trade dispute between US and China pushes copper price below 6,000 $ for the first time in a year. The industrial metal is down 2.6% to $ 5988 per ton

+++

13:22

Oil prices fell on Thursday. After the prices had changed little in the morning, it was significantly down in the noon trade. A barrel (159 liters) of the North Sea Brent for delivery last September cost $ 71.86. That was $ 1.04 less than the day before. The price of American oil for delivery in August dropped 92 cents to $ 67.84.

Market observers referred to the recent development of US oil reserves and US production. The day before, the US government surprisingly reported an increase in crude oil inventories last week from 5.8 million barrels to 411.1 million barrels. In contrast, analysts expected a drop of 3.5 million barrels. In addition, it was reported at the same time that US oil production reached a new record of 11 million barrels a day.

+++

12:00

The Swiss stock market shows Thursday morning a little firmer. After a slightly weaker opening, the indices – initially the SMI – turned into the morning trade in the most. The Swiss Market Index (SMI) rose 0.2% to 8,956 points. The market is supported by heavyweights Nestlé (+ 0.5%) and Novartis (+ 0.7%). They continue to benefit from the good half-year results published by the pharmaceutical company on Wednesday

. However, the focus is on ABB which gained 4.6%, ahead of SMI ahead of Credit Suisse (+ 0.7%), Novartis (+ 0.6%). , 7%) and UBS (+ 0.6%). Roche is down 1.1%. It is there that data from the study on immunotherapeutic Tecentriq in lung cancer put pressure on

Kuehne + Nagel (-2%), who were still among the winners in the first cases, also refused.

In the broad segment, Dormakaba in particular 17.5% ahead of Bobst (-16.7%), Rieter (-12.2%), Meyer Burger (-10.5%) and Leonteq (-11.7%) %).

Financial statements The announcements of these companies all contained a decline for shareholders. For example, the financial technology firm Leonteq, which has convincingly operational, no longer wants to pay dividends and also plans a capital increase.

Meyer Burger, on the other hand, managed to regain profit after several quarters. However, analysts expect nothing good in the near future

Bobst packaging machine manufacturer has issued a warning on profits and closing technology company Dormakaba had to postpone its goals to medium term up to two years. however, titles lose 6.3%. This is what is called taking profits after a good exercise this year

+++

11:01

Disappointing numbers on the # 39, British consumers' mood is another blow to the country's currency. The pound lost a little less than half a dollar on Thursday and $ 1.2981 was as cheap as it was eleven months ago. Retailers only increased their sales in June by 2.9%, after 4.1% the previous month. Analysts polled by Reuters forecast growth of 3.7%. This speculation has moderated that the Bank of England (BoE) would raise interest rates shortly after surprisingly low inflation was announced Wednesday.

+++

10:32

The euro fell further on Thursday. In the morning, the common currency reached its lowest point of the day at $ 1,1606. It was lower than the day before

The European currency is also slightly weaker against the Swiss franc. Currently, the euro exchange at 1.1623 francs after 1.1638 francs at the beginning of the session. The dollar, meanwhile, returned to parity, trading at CHF 1 0006 after CHF 0.9992 in the morning.

+++

10:27

The shares of Leonteq are recorded Losses above average Thursday morning. The fintech company had surpassed the expectations of analysts with its half-year results. However, market participants are confused that the company intends to suspend the dividend in the near future and also wants to increase its capital.

The shares of Leonteq will lose 10 per cent to CHF 55.65 until around 10.10 am – in the meantime the valuables had even returned to 52.50 francs. The global market (SPI) is 0.14% lower. About three times the average trading volume was realized at that time.

Thanks to good customer demand and a favorable market environment, Leonteq has significantly increased its profits and significantly exceeded profit forecasts. "So we can definitely talk about a successful recovery," writes Michael Kunz of ZKB in a comment.

The strong operating result is however overshadowed by the announced capital increase, in addition to UBS banking experts. These assume that this loan will lead to a dilution of their earnings per share forecast of 16%.

+++

10:26

The shares of Rieter are at the beginning of the negotiations broken on Thursday. The spinning machine manufacturer is disappointing with its half-yearly figures: it's the backbone of the orders and profitability. Management expects slightly lower targets for the current year

The Rieter share fell 14.0% to 157.10 francs out of 9.55, while the overall market, measured by the SPI index, is down 0.18%.

Rieter reported an increase in sales on Thursday. But the company can boast only a few new orders. Profitability is also down. At 2.7%, the current EBIT margin is far from the medium-term target of 10%. Nevertheless, this has been confirmed. And management is also maintaining its sales target for the current year: revenues are expected to exceed the previous year.

Analysts were skeptical. UBS writes further decline in profitability

+++

10:00

The stock of the closing company of Dormakaba collapses on Thursday morning. The company had to carry forward the medium-term objectives announced for two years. Given the revised outlook, investors and analysts are disappointed. At 10 am, the Dormakaba newspapers collapse from about 15% to 628 francs. Previously, the stock was less than 616 francs. These are values ​​that were achieved more than two years ago. The overall market (SPI), meanwhile, is slightly below -0.13 percent.

+++

09:15

The Swiss stock market starts unequally on Thursday. There are few uprisings and a number of mid-term stock collisions. The Swiss market index is 0.07% higher after trading. Overseas specifications are neutral to friendly. Wall Street barely responded to the publication of the US Federal Reserve's economic report, the Beige Book. The day before, the US Federal Reserve Chairman, Jerome Powell, in his statement to the Senate, described the state of the US economy as good.

The focus is on ABB shares that earn 4.3%. The industrial group recorded moderate growth with improved profit margin in the second quarter. In terms of profits, it exceeded the consensus expectations of analysts.

The SMI is also supported by the shares of the pharmaceutical company Novartis (+ 0.2%), which had published yesterday solid figures. Many blue chips tend to be deeper. Givaudan is down 3.2%, although the world's largest fragrance and fragrance company outperformed the market expectations with its half-year results.

Disappointing results have also added to the title of pharmaceutical giant Roche. The Genusscheine loses 1.3% early in the session, making it one of the latecomers of the Swiss default values. Tecentric immunotherapy, in combination with chemotherapy in patients with lung cancer, reduces the risk of disease progression. However, Roche has not yet provided final data on the survival rate of patients. This Tecentriq has a delay on competing product Keytruda from the US Merck, said Bruno Bulic, an analyst at Baader Helvea. He posed a question mark behind the mechanism of action Tecentriq

Kuehne + Nagel can look forward to a successful semester (+ 0.7%). On the whole of the main results, the Group recorded a significant increase compared to the same period of the previous year.

In the broad segment, Rieter (-13%), Dormakaba (-16%) and Leonteq (-9%) are in the spotlight. , Rieter recorded a significant increase in sales, but order intake was slow.

Although Dormakaba increased its sales and EBITDA, organic growth and EBITDA margin were lower than the company's expectations. Leonteq has finally exceeded analysts' forecasts with its results. Temenos loses 4% after semiannual figures, Bobst 9%

+++

08:10

According to calculations by Julius Baer, ​​the Swiss market index is 0.08 percent higher than the exchange rate before trading. The information should be taken with caution, she came in pre-exchange course to several adventurous sweeps in the courses.

The day before, the index advanced by 1.3% to its highest level since the end of May. The focus has been on ABB shares, which have gained more than two percent before the stock market. Despite the steady decline in sales, the electrical engineering group gained more in the second quarter of 2018. The company's earnings climbed 30% to $ 681 million, outpacing analysts' forecasts of $ 631 million.

Givaudan shares fell 0.6% after falling in the first half of the year before the official start of trading.

After a warning on profits, Dormakaba and after a decline in profits in Rieter, it should arrive at discounts, while in Leonteq, the expected capital increase over the price should be likely. However, Kuehne + Nagel's shares are expected to grow in the first half.

+++

06:30

The Nikkei index, Japanese leader, is down 0.1%, having been in positive territory for a long time . The Chinese stock exchange in Shanghai came on the spot, just like the Hang Seng in Hong Kong. On Wall Street, especially the balance sheets of the big bank Morgan Stanley and United Airlines had reassured investors

+++

06:25

The euro has moved little on the Forex market in the Far East. He walked at $ 1.1644 on the spot. The Swiss franc was also slightly different from the euro at 1.1630 and the dollar at 0.9988.

(species / AWP / Reuters)

[ad_2]
Source link

Tags

Powered by https://naaju.com/switzerland | Designed by Naaju
© Copyright 2024, All Rights Reserved